Lifecycle Regulation: De-Risking AI’s Trillion-Dollar Cardiac Future
The way we regulate AI in cardiology is changing completely. We’re moving from a world of one-time, static approvals to a more dynamic model that…
The way we regulate AI in cardiology is changing completely. We’re moving from a world of one-time, static approvals to a more dynamic model that…
AI in ECG interpretation is here, and it’s creating a common headache for cardiologists. What do you do when an AI-enabled ECG flags a patient…
AliveCor’s remarkable achievement of 39 FDA cardiac determinations raises critical questions about the durability of investment in the FDA Center for Devices and Radiological Health…
The intersection of artificial intelligence and healthcare is rife with both unparalleled promise and significant regulatory complexities. As capital flows into this burgeoning sector, investors,…
We keep hearing about AI in healthcare, with the idea that algorithms can see patterns doctors can’t and predict disease before it hits. For a…
AI’s potential in healthcare depends entirely on its equitable application. As we integrate clinical AI into patient care, we’re running headlong into algorithmic bias. This…
The integration of artificial intelligence into healthcare is set to improve diagnostics, and for cardiac imaging, this brings both tangible potential and serious operational complexities.…
The fast development of AI in healthcare brings huge opportunities and real headaches for clinical integration. For cardiology and neurology units, putting AI-driven stroke detection…
The promise of AI in cardiology is vast, but its clinical integration hinges on a singular, non-negotiable factor: robust, peer-reviewed evidence. For clinicians and investors…
The promise of machine learning to revolutionize cardiology is undeniable, offering unprecedented opportunities for early disease detection, risk stratification, and personalized treatment. Yet, for clinicians…